Register now and start receiving our tailored medical education content from April. You can also secure your place for the first live webinar.
30-06-2023 | Prostate cancer | News
Adding talazoparib to enzalutamide significantly improves the outcomes of untreated patients with metastatic castration-resistant prostate cancer, regardless of homologous recombination repair mutation status, shows the TALAPRO-2 trial.
06-06-2023 | Non-small-cell lung cancer | Conference coverage | News
Adjuvant treatment with osimertinib significantly prolongs overall survival relative to placebo in people with EGFR-mutated, early-stage non-small-cell lung cancer, show trial results.
16-08-2023 | Breast cancer | News
Preliminary MASAI trial results indicate that AI-supported mammography has a similar rate of breast cancer detection to standard double reading while reducing the screen-reading workload.
30-08-2023 | COVID-19 | News
An analysis of the CCC19 registry has demonstrated a significant link between receipt of anticancer therapies within 3 months of a COVID-19 diagnosis and an elevated risk for venous thromboembolism
Interviews with clinical experts on cancer patient care